The shares of the prominent pharmaceutical company gained up to 12 percent after the company’s net profit and revenue increased by 800 percent and 13 percent YoY, respectively in Q4.
Price movement
With a market capitalization of Rs 3,695.48 crore, the shares of RPG Life Sciences Ltd were trading at Rs 2,234.40 per share, increasing around 6 percent as compared to the previous closing price of Rs 2,108.80 apiece.
Reason for Rise
The shares of RPG Life Sciences Ltd have seen bullish movement after reporting positive results in Q4FY25, Revenue decreased by 17 percent on a quarter-on-quarter basis from Rs 173 crore in Q3FY25 to Rs 143 crore in Q4FY25. Further, revenue zoomed by 13 percent year on year, from Rs 127 crore in Q4FY24 to Rs 143 crore in Q4FY25.
The company’s net profit increased by 234 percent on a quarter-on-quarter basis, from Rs. 35 crore in Q3FY25 to Rs. 117 crore in Q4FY25. Further, net profit magnified significantly by 800 percent year on year from Rs 13 crore in Q4FY24 to Rs 117 crore in Q4FY25.
The company posted a strong FY24- 25 performance, with revenue surging 12 percent from Rs 582 crore to Rs 653 crore. Net profit jumped 108 percent, rising from Rs 88 crore to Rs 183 crore, reflecting robust growth and improved profitability over the previous financial year.
Additionally, the board approved a final dividend of Rs. 20 per equity share (250% on the face value of Rs 8 each) and a special dividend of Rs. 4 per equity share (50% on the face value of Rs. 8 each.
Also read: Cable stock jumps 4% after receiving ₹230 Cr order for supply of power cables
Operations Overview
RPG Life Sciences operates across domestic formulations (66%), international formulations (19%), and APIs (15%). The company develops branded and generic formulations for India, Nepal, and global markets, along with high-value synthetic APIs.
International Presence
RPG Life Sciences’ International Formulations segment has a strong foothold in immunosuppressants and a reliable supply record. It maintains global footprints across regulated and emerging markets—Canada, UK, Germany, France, Australia, South East Asia, and Africa—supported by quality excellence and continuous investments in plant upgradation and capacity expansi
Company Overview
RPG Life Sciences Limited is an India-based pharmaceutical company. The Company operates in the domestic and international markets in the formulations, generics, and synthetic active pharmaceutical ingredients (APIs) space. Its business portfolio includes domestic formulations, international formulations and APIs.
Written by Abhishek Singh
Disclaimer
The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Dailyraven Technologies or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.
